Page 2 of 12 – SEC Filing 1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Caxton Corporation 22-2437619 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [X] 3. SEC USE ONLY 4. SOURCE OF FUNDS AF 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_] 6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON 7. SOLE VOTING POWER 0 8. SHARED VOTING POWER 12,057,869 9. SOLE DISPOSITIVE POWER 0 10. SHARED DISPOSITIVE POWER 12,057,869 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON 12,057,869 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [_] 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 8.7% 14. TYPE OF REPORTING PERSON CO
Follow Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL)
Follow Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
1. | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | |
Caxton Corporation 22-2437619 | ||
2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) [_] |
(b) [X] | ||
3. | SEC USE ONLY | |
4. | SOURCE OF FUNDS | |
AF | ||
5. | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) | [_] |
6. | CITIZENSHIP OR PLACE OF ORGANIZATION | |
Delaware | ||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||
7. | SOLE VOTING POWER | |
0 | ||
8. | SHARED VOTING POWER | |
12,057,869 | ||
9. | SOLE DISPOSITIVE POWER | |
0 | ||
10. | SHARED DISPOSITIVE POWER | |
12,057,869 | ||
11. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |
12,057,869 | ||
12. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES | [_] |
13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) | |
8.7% | ||
14. | TYPE OF REPORTING PERSON | |
CO |